Exciting news for tech enthusiasts and investors! On April 30, StrictlyVC San Francisco will host a special event featuring leaders from notable companies such as TDK Ventures and Replit. This gathering aims to connect influential figures in the tech in

How AI is helping solve the labor issue in treating rare diseases Modern biotech has the tools to edit genes and design drugs, yet thousands of rare diseases remain untreated. According to executives from Insilico Medicine and GenEditBio, the missing ingredient for years has been finding enough smart people to continue the work. AI, they say, is becoming the force multiplier that lets...

Awadh, Uttar Pradesh: India is restoring a centuries-old royal kitchen that never stopped serving foodAman/BBCThe royal kitchen of the former Awadh kingdom has been serving meals for almost 200 yearsIn northern India's Uttar Pradesh state, a team of workers is carefully restoring a centuries-old royal kitchen that once fed the rulers of the former princely state of Awadh.Tucked within the...

My Galaxy A17 Review: Samsung's $200 Phone Does It All... Slowly Samsung Galaxy A17 5G Pros Big and bright screen Good photos for the price Six years of software and security support Cons Multitasking can be rough Noticeably sluggish My Galaxy A17 Review: Samsung's...

Kurasks are a mid-to-high-level Slayer monster in Old School RuneScape that offer strong Slayer experience and consistent utility drops. Requiring 70 Slayer and 65 Combat, Kurasks are an excellent task with OSRS Fire Cape for players progressing through the mid-game, especially those looking to balance experience with profitability and efficiency.Before starting, it is important to understand...

China’s brain-computer interface industry is racing ahead While Elon Musk’s Neuralink likes to say it’s “pioneering” brain-computer interfaces (BCIs), China’s BCI industry is already quietly moving from research to scale. A new wave of startups is racing to commercialize both implantable and noninvasive BCIs, backed by stronger policy support, expanding clinical trials, and growing investor...